News
Spirair announced today that the FDA granted 510 (k) clearance for its TurbAlign bioabsorbable implant device. The company ...
Reductions in chronic rhinosinusitis symptom severity from 2017 to 2023 are due to clinical practice and not anatomical variation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback